The Kent Crime and Justice Centre, working with the UKC Psychedelics Society, invites you to an open lecture by Prof. David Nutt.

David Nutt holds the Edmond J. Safra Chair in Neuropsychopharmacology at Imperial College London. Until November 2009, he was Chair of the government’s Advisory Council on the Misuse of Drugs (ACMD). He was sacked by the Home Secretary, who disagreed with the evidence that Prof. Nutt was discussing in public.

The regulation of drugs – including alcohol and tobacco – is an issue of pressing importance due to the increasing health care costs associated with their use and the new sorts of synthetic agents being developed sold over the internet.

Prof. Nutt’s talk will reflect on these issues in the light of his ten year experience on the AMCD. He will present new analyses that compare the harms of drugs and alcohol using more sophisticated methodology and challenge many of the current misconceptions about drugs – their harms – and how to deal with them.

To register for this free event go to – http://www.doodle.com/fuui8ydryqcfe8zh

Wednesday 16th November, 6pm in Darwin Lecture theatre 1, University of Kent Canterbury.

Human ingestion of psychedelic plants is thought to stretch from pre-history to the present; in more recent epochs such rituals have been shadowed by attempts at their suppression. This talk looks at the latest efforts to stamp out this praxis on these shores … and what those of us committed to fighting for our cognitive liberty can do about it.

Charlotte Walsh is a legal academic whose research focus is on psychedelics and the law, viewed from a libertarian, human rights based perspective. She is a founder member of Drug Equality Alliance – an organisation that campaigns for equal rights and protection of all drug users – and is involved in advising individuals prosecuted for activities involving plant psychedelics.

Wednesday 6th November, 6pm, Darwin lecture theatre 1, University of Kent Canterbury.

Dr Notcutt has been involved in clinical trials regarding cannabis as treatment for pain, with specific regards to conditions such as multiple sclerosis and spinal chord injuries. His research has involved looking at the development, evaluation, and use of cannabinoid/cannabis-based medicines within the Western world. This research has particular implications with regards to the effect on the phenomonology of use of cannabis if prepared medicinally.